FdaApplication

ANDA 214496

Back to search

Identifiers

Properties

PropertyValue
applicant_nameEPIC PHARMA LLC
application_typeANDA
approval_date2023-06-01

Products (3)

ProductActive ingredientStrengthDosage form
PREGABALINPREGABALIN82.5MGTABLET, EXTENDED RELEASE;ORAL
PREGABALINPREGABALIN330MGTABLET, EXTENDED RELEASE;ORAL
PREGABALINPREGABALIN165MGTABLET, EXTENDED RELEASE;ORAL

3 products